CAMLG-CDG: a novel congenital disorder of glycosylation linked to defective membrane trafficking

Abstract The transmembrane domain recognition complex (TRC) pathway is required for the insertion of C-terminal tail-anchored (TA) proteins into the lipid bilayer of specific intracellular organelles such as the endoplasmic reticulum (ER) membrane. In order to facilitate correct insertion, the recognition complex (consisting of BAG6, GET4 and UBL4A) must first bind to TA proteins and then to GET3 (TRC40, ASNA1), which chaperones the protein to the ER membrane. Subsequently, GET1 (WRB) and CAML form a receptor that enables integration of the TA protein within the lipid bilayer. We report an individual with the homozygous c.633 + 4A>G splice variant in CAMLG, encoding CAML. This variant leads to aberrant splicing and lack of functional protein in patient-derived fibroblasts. The patient displays a predominantly neurological phenotype with psychomotor disability, hypotonia, epilepsy and structural brain abnormalities. Biochemically, a combined O-linked and type II N-linked glycosylation defect was found. Mislocalization of syntaxin-5 in patient fibroblasts and in siCAMLG deleted Hela cells confirms this as a consistent cellular marker of TRC dysfunction. Interestingly, the level of the v-SNARE Bet1L is also drastically reduced in both of these models, indicating a fundamental role of the TRC complex in the assembly of Golgi SNARE complexes. It also points towards a possible mechanism behind the hyposialylation of N and O-glycans. This is the first reported patient with pathogenic variants in CAMLG. CAMLG-CDG is the third disorder, after GET4 and GET3 deficiencies, caused by pathogenic variants in a member of the TRC pathway, further expanding this novel group of disorders.

[1]  Shyam M. Saladi,et al.  Sequence‐based features that are determinant for tail‐anchored membrane protein sorting in eukaryotes , 2021, Traffic.

[2]  Ákos Farkas,et al.  Capture and delivery of tail-anchored proteins to the endoplasmic reticulum , 2021, The Journal of cell biology.

[3]  G. Matthijs,et al.  SLC37A4‐CDG: Second patient , 2021, JIMD reports.

[4]  M. M. Ricardi,et al.  Endoplasmic reticulum membrane receptors of the GET pathway are conserved throughout eukaryotes , 2020, Proceedings of the National Academy of Sciences.

[5]  C. Robinson,et al.  Structural Basis of Tail-Anchored Membrane Protein Biogenesis by the GET Insertase Complex. , 2020, Molecular cell.

[6]  D. Nickerson,et al.  Mutations in GET4 disrupt the transmembrane domain recognition complex pathway , 2020, Journal of inherited metabolic disease.

[7]  G. van den Bogaart,et al.  Congenital disorder of glycosylation caused by starting site-specific variant in syntaxin-5 , 2020, Nature Communications.

[8]  S. Shan.  Guiding tail-anchored membrane proteins to the endoplasmic reticulum in a chaperone cascade , 2019, The Journal of Biological Chemistry.

[9]  R. Hegde,et al.  Biallelic Variants in ASNA1, Encoding a Cytosolic Targeting Factor of Tail-Anchored Proteins, Cause Rapidly Progressive Pediatric Cardiomyopathy , 2019, Circulation. Genomic and precision medicine.

[10]  Xinran Liu,et al.  Golgin45-Syntaxin5 Interaction Contributes to Structural Integrity of the Golgi Stack , 2019, Scientific Reports.

[11]  V. Lupashin,et al.  Maintaining order: COG complex controls Golgi trafficking, processing, and sorting , 2019, FEBS letters.

[12]  G. van den Bogaart,et al.  Stx5-Mediated ER-Golgi Transport in Mammals and Yeast , 2019, Cells.

[13]  C. Lenz,et al.  A trap mutant reveals the physiological client spectrum of TRC40 , 2019, Journal of Cell Science.

[14]  M. Bekier,et al.  Knockout of the Golgi stacking proteins GRASP55 and GRASP65 impairs Golgi structure and function , 2017, Molecular biology of the cell.

[15]  M. Schrader,et al.  Predicting the targeting of tail-anchored proteins to subcellular compartments in mammalian cells , 2017, Journal of Cell Science.

[16]  G. Matthijs,et al.  Galactose Supplementation in Patients With TMEM165-CDG Rescues the Glycosylation Defects , 2017, The Journal of clinical endocrinology and metabolism.

[17]  R. Hegde,et al.  Mechanistic basis for a molecular triage reaction , 2017, Science.

[18]  J. Weissman,et al.  The SND proteins constitute an alternative targeting route to the endoplasmic reticulum , 2016, Nature.

[19]  R. Hegde,et al.  Protein Targeting and Degradation are Coupled for Elimination of Mislocalized Proteins , 2011, Nature.

[20]  Gert Matthijs,et al.  Differential effects of lobe A and lobe B of the Conserved Oligomeric Golgi complex on the stability of {beta}1,4-galactosyltransferase 1 and {alpha}2,6-sialyltransferase 1. , 2011, Glycobiology.

[21]  W. Horton,et al.  Crude subcellular fractionation of cultured mammalian cell lines , 2009, BMC Research Notes.

[22]  F. Foulquier.  COG defects, birth and rise! , 2009, Biochimica et biophysica acta.

[23]  J. Jaeken,et al.  Multiplexed glycoproteomic analysis of glycosylation disorders by sequential yolk immunoglobulins immunoseparation and MALDI‐TOF MS , 2008, Proteomics.

[24]  N. Callewaert,et al.  Conserved oligomeric Golgi complex subunit 1 deficiency reveals a previously uncharacterized congenital disorder of glycosylation type II. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[25]  R. Wevers,et al.  Apolipoprotein C-III isofocusing in the diagnosis of genetic defects in O-glycan biosynthesis. , 2003, Clinical chemistry.

[26]  J. V. van Deursen,et al.  CAML is required for efficient EGF receptor recycling. , 2003, Developmental cell.

[27]  D. James,et al.  GS15 forms a SNARE complex with syntaxin 5, GS28, and Ykt6 and is implicated in traffic in the early cisternae of the Golgi apparatus. , 2002, Molecular biology of the cell.

[28]  J. Jaeken,et al.  Diagnosis of congenital disorders of glycosylation by capillary zone electrophoresis of serum transferrin. , 2004, Clinical chemistry.